This nested, matched case control study tested the hypothesis that incidental nodal irradiation during stereotactic body radiation therapy for early stage non-small cell lung cancer reduces the risk of nodal relapse. The analysis suggests that incidental hilar doses greater than 20 Gy are associated with fewer hilar relapses.

To read the full research paper as published in the Red Journal in May 2014 please download the pdf below

Patterns of Nodal Relapse when treated with SBRT